Search Results

There are 4861 results for: content related to: Tegaserod, a 5-HT 4 receptor partial agonist, decreases sensitivity to rectal distension in healthy subjects

  1. You have free access to this content
    Influence of tegaserod on proximal gastric tone and on the perception of gastric distension

    Alimentary Pharmacology & Therapeutics

    Volume 18, Issue 10, November 2003, Pages: 1031–1037, J. Tack, R. Vos, J. Janssens, J. Salter, S. Jauffret and G. Vandeplassche

    Article first published online : 20 OCT 2003, DOI: 10.1046/j.1365-2036.2003.01775.x

  2. You have free access to this content
    Sensory signalling effects of tegaserod in patients with irritable bowel syndrome with constipation

    Neurogastroenterology & Motility

    Volume 20, Issue 2, February 2008, Pages: 134–141, J.-m. Sabaté, D. Bouhassira, C. Poupardin, A. Wagner, Y. Loria and B. Coffin

    Article first published online : 14 NOV 2007, DOI: 10.1111/j.1365-2982.2007.01030.x

  3. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation

    Intervention Review

    The Cochrane Library

    Beti W Evans, Wendy K Clark, David J Moore and Peter J Whorwell

    Published Online : 17 OCT 2007, DOI: 10.1002/14651858.CD003960.pub3

  4. You have free access to this content
    Clinical trial: effects of tegaserod on gastric motor and sensory function in patients with functional dyspepsia

    Alimentary Pharmacology & Therapeutics

    Volume 26, Issue 10, November 2007, Pages: 1399–1407, M. THUMSHIRN, H. FRUEHAUF, B. STUTZ, G. TOUGAS, J. SALTER and M. FRIED

    Article first published online : 24 SEP 2007, DOI: 10.1111/j.1365-2036.2007.03521.x

  5. You have free access to this content
    Activation of peripheral 5-HT4 receptors attenuates colonic sensitivity to intraluminal distension

    Neurogastroenterology & Motility

    Volume 18, Issue 1, January 2006, Pages: 76–86, B. Greenwood-van Meerveld, K. Venkova, G. Hicks, E. Dennis and M. D. Crowell

    Article first published online : 14 OCT 2005, DOI: 10.1111/j.1365-2982.2005.00723.x

  6. You have free access to this content
    Influence of tegaserod on proximal gastric tone and on the perception of gastric distention in functional dyspepsia

    Neurogastroenterology & Motility

    Volume 23, Issue 2, February 2011, Pages: e32–e39, J. Tack, P. Janssen, R. Bisschops, R. Vos, T. Phillips and G. Tougas

    Article first published online : 27 OCT 2010, DOI: 10.1111/j.1365-2982.2010.01613.x

  7. Influence of a new 5-HT4 receptor partial agonist, YKP10811, on visceral hypersensitivity in rats triggered by stress and inflammation

    Neurogastroenterology & Motility

    Volume 26, Issue 12, December 2014, Pages: 1761–1770, M. Gilet, H. Eutamene, H. Han, H. W. Kim and L. Bueno

    Article first published online : 15 OCT 2014, DOI: 10.1111/nmo.12458

  8. Tegaserod for Constipation-Predominant Irritable Bowel Syndrome

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 27, Issue 2, February 2007, Pages: 267–277, Pramodini B. Kale-Pradhan and Sheila M. Wilhelm

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.27.2.267

  9. You have free access to this content
    Tegaserod

    Alimentary Pharmacology & Therapeutics

    Volume 15, Issue 3, March 2001, Pages: 277–289, M. Camilleri

    Article first published online : 7 JUL 2008, DOI: 10.1046/j.1365-2036.2001.00925.x

  10. You have free access to this content
    Oral Presentations

    Neurogastroenterology & Motility

    Volume 17, Issue s2, July 2005, Pages: 1–27,

    Article first published online : 15 AUG 2005, DOI: 10.1111/j.1365-2982.2005.00698_1.x

  11. You have free access to this content
    Review article: the safety profile of tegaserod

    Alimentary Pharmacology & Therapeutics

    Volume 20, Issue s7, November 2004, Pages: 25–30, P. Schoenfeld

    Article first published online : 1 NOV 2004, DOI: 10.1111/j.1365-2036.2004.02182.x

  12. Tegaserod Pharmacokinetics Are Similar in Patients with Severe Renal Insufficiency and in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 43, Issue 4, April 2003, Pages: 359–364, Dr Suzanne K. Swan, Dr Honghui Zhou, Dr Ann Horowitz, Dr Latifa Alladina, Dr Martine Hubert, Dr Silke Appel-Dingemanse, Mr Stuart Osborne, Dr Larry Lambrecht and Dr James F. McLeod

    Article first published online : 8 MAR 2013, DOI: 10.1177/0091270003251823

  13. You have free access to this content
    Abstracts of papers accepted for presentation at the XVIII International Symposium on Neurogastroenterology and Motility

    Neurogastroenterology & Motility

    Volume 13, Issue 4, August 2001, Pages: 371–448,

    Article first published online : 16 JUL 2009, DOI: 10.1046/j.1365-2982.2001.00001.x

  14. Safety, tolerability and satisfaction with tegaserod therapy in Asia–Pacific patients with irritable bowel syndrome with constipation

    Journal of Gastroenterology and Hepatology

    Volume 22, Issue 8, August 2007, Pages: 1190–1198, Kwong M Fock, Amy Wagner and the Asia Pacific Gastroenterology Group

    Article first published online : 24 MAY 2007, DOI: 10.1111/j.1440-1746.2007.04955.x

  15. The Effects of Tegaserod (HTF 919) on the Pharmacokinetics and Pharmacodynamics of Digoxin in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 41, Issue 10, October 2001, Pages: 1131–1139, Dr. Honghui Zhou, Dr. Patricia C. Ledford, Dr. Martine Hubert, Dr. Silke Appel-Dingemanse, Mr. Stuart Osborne and Dr. James F. McLeod

    Article first published online : 8 MAR 2013, DOI: 10.1177/00912700122012625

  16. You have free access to this content
    Alosetron, cilansetron and tegaserod modify mesenteric but not colonic blood flow in rats

    British Journal of Pharmacology

    Volume 158, Issue 5, November 2009, Pages: 1210–1226, Evelin Painsipp, Anaid Shahbazian and Peter Holzer

    Article first published online : 28 SEP 2009, DOI: 10.1111/j.1476-5381.2009.00392.x

  17. Effect of 5-hydroxytryptamine receptor 4 agonist mosapride on human gastric accommodation

    Neurogastroenterology & Motility

    Volume 27, Issue 9, September 2015, Pages: 1303–1309, T. Amano, H. Ariga, A. Kurematsu, S. Yamato, S. Morioka, A. Masaka, M. Kanazawa and S. Fukudo

    Article first published online : 25 AUG 2015, DOI: 10.1111/nmo.12623

  18. You have free access to this content
    The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo

    British Journal of Pharmacology

    Volume 143, Issue 5, November 2004, Pages: 549–560, D T Beattie, J A M Smith, D Marquess, R G Vickery, S R Armstrong, T Pulido-Rios, J L McCullough, C Sandlund, C Richardson, N Mai and P P A Humphrey

    Article first published online : 17 FEB 2009, DOI: 10.1038/sj.bjp.0705929

  19. You have free access to this content
    Role of serotonin in the pathophysiology of the irritable bowel syndrome

    British Journal of Pharmacology

    Volume 141, Issue 8, April 2004, Pages: 1285–1293, Michael D Crowell

    Article first published online : 30 JAN 2009, DOI: 10.1038/sj.bjp.0705762

  20. You have free access to this content
    Poster Abstracts

    Neurogastroenterology & Motility

    Volume 17, Issue s2, July 2005, Pages: 27–85,

    Article first published online : 15 AUG 2005, DOI: 10.1111/j.1365-2982.2005.00698_2.x